Open guide.

SAFETY BRIEF · COMMON IS NOT TRIVIAL

Approved does not mean right for everyone

MYTH.FDA approval means there is little to discuss about risk.

FACT.Approval comes with a detailed label. It names common effects and grave harms. It also tells the prescribing doctor what to ask.

Read the label. Take one part at a time. Bring the full history. Ask what changes the plan. Some effects are common. Some are rare and grave. The facts are not all equal. Pause. Ask again. A person’s history changes the picture.

Forest path after rain beneath a deep purple evening sky

Stomach effects are common

In the Wegovy weight-management trials, nausea affected 44 in 100 people receiving the injection and 16 in 100 receiving a placebo, a dummy shot with no medicine. Diarrhea, vomiting and constipation were also common.

The label also reports severe stomach reactions and warns that fluid loss from vomiting or diarrhea can harm the kidneys.

Common does not mean imaginary, and serious does not mean common. The label keeps those ideas separate.

What the box says about the thyroid

Every semaglutide label carries a boxed warning, the FDA’s strongest kind, because thyroid tumors grew in rats and mice given the drug. They were C-cell tumors, which start in one kind of thyroid cell. Nobody knows yet whether semaglutide causes them in people.

The label rules semaglutide out for anyone who has had a rare thyroid cancer called medullary thyroid cancer, or has a close relative who had it. It also rules it out for people with MEN 2, a rare inherited condition, and after a serious allergic reaction to semaglutide. If you are unsure whether either name appears in your family history, ask your doctor to check your records.

Tell the surgical team

Semaglutide slows how fast the stomach empties. The label asks patients to tell the team before any operation or procedure where they will be put to sleep or deeply sedated, meaning given drugs that make them very drowsy. If you are unsure whether a planned procedure counts, tell the team anyway.

The label does not settle whether stopping beforehand reduces the risk.

That decision belongs with the treating and surgical teams.

ANNOTATED READING LIST

Evidence, with a note on why it belongs

  1. Wegovy prescribing information at DailyMed.The current label is the main source for common side effects, the boxed warning and the conditions that rule the medicine out.
  2. Ozempic prescribing information at DailyMed.The Ozempic label carries the same boxed warning and lists what Ozempic itself is approved to treat.